Data-Driven Ageing Model

Updated 1 February 2026

Data-driven ageing model is a computational framework that uses high-dimensional empirical data to capture dynamic, multidimensional trajectories of ageing.
It leverages advanced feature engineering, including slope features and latent variable methods, to enhance prediction accuracy and interpretability.
The framework is applied across biomedical and engineered systems to forecast individual ageing, support intervention strategies, and inform resource allocation.

A data-driven ageing model is a computational framework that infers the trajectory, rate, and dimensions of ageing in biological, physiological, or engineered systems directly from high-dimensional empirical data. These models leverage cross-sectional or longitudinal measurements—such as clinical biomarkers, molecular profiles, or sensor readouts—to capture individual- or population-level age dynamics, identify multidimensional ageing axes, and forecast future health or degradation states. Such models are fundamentally empirical: they minimize or bypass mechanistic assumptions in favor of predictive or generative accuracy, and highlight the temporal, nonlinear, and personalized nature of ageing processes.

1. Foundations and Key Concepts

Data-driven ageing models are distinguished by their reliance on comprehensive observational datasets and advanced feature engineering or representation learning techniques. Central to their formulation is the shift from static, cross-sectional age predictors to frameworks that model temporal change (e.g., biomarker velocities, latent health states) and multidimensional trajectories.

A core conceptual advance is the explicit modeling of “ageing velocity” or slope features, defined as annualized rates of change in key biomarkers, rather than simply utilizing baseline values. The explicit inclusion of these slope features allows models to detect individuals’ recent physiological trajectories, substantially improving age and risk prediction, and providing a more dynamic representation of ageing than snapshot-based methods (Dunbayeva et al., 13 Aug 2025).

2. Model Construction: Data Preprocessing and Feature Engineering

Building a data-driven ageing model requires rigorous cohort design, data curation, and mathematical feature construction:

Cohort Selection: Richly phenotyped, longitudinal cohorts form the basis, such as the Human Phenotype Project (HPP; N>10,000, ages 40–70, biennial follow-up) (Dunbayeva et al., 13 Aug 2025).
Preprocessing: Missing baseline values are imputed (sex-specific medians), and slopes are computed only where paired measurements exist.
Feature Set:
- Static features: Anthropometric indices (BMI, WHR), cardiovascular metrics (systolic/diastolic BP, IMT), metabolic markers (HbA1c, lipid panels), sleep measures, lifestyle variables.
- Interaction terms: Product or nonlinear combinations (e.g., BMI × SBP, squared WHR).
- Longitudinal slope features: For biomarker $y$ , $\beta_y = (y_{\text{Wave 2}} - y_{\text{Wave 1}})/(t_{\text{Wave 2}} - t_{\text{Wave 1}})$ (units/year), encoding dynamic change (Dunbayeva et al., 13 Aug 2025).

This mathematical formalism generalizes across applications, with variants including latent autoregressive dynamics (Pierson et al., 2018), variational autoencoders (VAEs) for multidimensional ageing rates (Santos et al., 2021), or physical system degradation with timescale separation (Desai et al., 2023).

3. Predictive Modeling Frameworks

The computational backbone for these models is typically one or more of the following advanced learning architectures:

Tree-based Methods: LightGBM regressors are empirically shown to outperform regularized linear (ElasticNet) and ensemble (RandomForest) models in biological age forecasting, especially when provided with engineered slope features. The LightGBM regularizes via a complexity term $\Omega(f_m) = \gamma T + \frac{\lambda}{2}\sum_{j=1}^T w_j^2$ (Dunbayeva et al., 13 Aug 2025).
Latent Variable Models: Deep generative models recover interpretable, multidimensional ageing axes via monotonic flows (Pierson et al., 2018) or VAEs with constrained latent structures (Santos et al., 2021), even from purely cross-sectional data.
Sequence and Dynamical Models: LSTM-based encoders/decoders accommodate physical and cognitive health trajectories over repeated assessments, capturing latent heterogeneity and enabling robust future state prediction (Chen et al., 2024).
Gaussian Process Regression: GP-based models provide nonparametric, uncertainty-aware estimation of battery or system ageing curves, adapting as new operational data is acquired and naturally capturing stress-factor dependencies (M. et al., 25 Jan 2026, M. et al., 25 Jan 2026).

Model selection and hyperparameter tuning (e.g., LightGBM: num_leaves ≈ 31, learning_rate ≈ 0.05, n_estimators ≈ 1000) are performed using cross-validated or grid/Bayesian optimization techniques.

4. Evaluation Metrics and Validation Strategies

Rigorous assessment of model performance requires both temporally-structured validation and interpretable metrics:

Temporal Validation: Models are trained on initial data waves and tested directly on follow-up waves, ensuring that generalization encompasses both static and slope features (Dunbayeva et al., 13 Aug 2025).
Predictive Metrics: The coefficient of determination ( $R^2$ ), root mean square error (RMSE), and mean absolute error (MAE) quantify chronological age prediction accuracy. For example, LightGBM with slope features achieved $R^2 = 0.498$ (females), $0.515$ (males) and RMSE ≈ 6.1 years, outperforming ElasticNet ( $R^2$ ≈ 0.11) and RandomForest ( $R^2$ ≈ 0.23) (Dunbayeva et al., 13 Aug 2025).
Interpretability: SHAP (SHapley Additive exPlanations) analyses identify the dominant predictors (e.g., LDL slope, BMI slope) in tree-based models, while latent variable mappings from neural models are linked to specific dimensions (e.g., renal, liver, cardiovascular ageing) (Dunbayeva et al., 13 Aug 2025, Pierson et al., 2018, Santos et al., 2021).
Downstream Risk and Health Economics: Odds ratios for disease incidence, health care expenditures, and cluster-wise profiling of resource use provide real-world relevance (Santos et al., 2021, Chen et al., 2024).

5. Interpretability and Multidimensional Ageing Axes

Data-driven models can uncover multidimensional and interpretable axes of ageing:

Organ-System Specificity: Latent factors strongly correlate with independently-measured markers—e.g., one axis may correspond to renal decline (eGFR), another to liver function (ALT, AST), and a third to cardiovascular deterioration (SBP) (Pierson et al., 2018).
Trajectory Clustering: K-means or tSNE clustering of latent representations reveals clinically distinct subgroups, enabling differential resource allocation, targeted risk assessment, and hypothesis generation regarding ageing heterogeneity (Chen et al., 2024).
Dynamic Feature Dominance: SHAP-based analyses consistently indicate that recent biomarker change (“velocity”) has greater predictive power for future biological age and adverse health events than static baseline readings (Dunbayeva et al., 13 Aug 2025).

Interpretable models further facilitate “what-if” counterfactual scenario simulation—perturbing input features (e.g., improving sleep efficiency, reducing LDL slopes) enables exploration of potential interventions’ impacts on ageing forecasts.

6. Applications and Implications

The translational potential spans several domains:

Clinical Integration: Embedding models within electronic health records allows computation of biological age at point-of-care, tracking individual trajectories, and flagging accelerated agers for early intervention and personalized prevention (Dunbayeva et al., 13 Aug 2025).
Trial Endpoints: The biological age delta ( $\Delta BA = \widehat{BA} - CA$ ) serves as a sensitive, continuous quantitative endpoint for geroprotective clinical trials, augmenting or replacing slow clinical-event-based designs (Dunbayeva et al., 13 Aug 2025).
Resource Allocation and Policy: Models identifying high health care spenders or those at elevated risk for morbidity inform health system planning and resource allocation (Santos et al., 2021, Chen et al., 2024).
Synthetic Data Generation: Advanced stochastic dynamical models (e.g., DJIN) simulate realistic ageing trajectories for synthetic population modeling and imputation under missing data (Farrell et al., 2021).
Battery and System Health Monitoring: Data-driven models generalize to engineered systems, providing robust, adaptive, and uncertainty-quantified lifespan forecasts under dynamic operational regimes (M. et al., 25 Jan 2026, Desai et al., 2023).

7. Limitations and Prospects for Future Research

Limitations of current models stem from cohort homogeneity (geographical, ethnic), limited to clinical biomarkers (excluding multi-omics), and potential unmeasured confounders. Key priorities include:

External Validation: Expanding and recalibrating models in large, diverse cohorts such as the UK Biobank or NHANES to ensure generalizability (Dunbayeva et al., 13 Aug 2025).
Multi-Omic Integration: Incorporating epigenetic, proteomic, or metabolomic features for multi-scale clocks and deeper system-level understanding.
Causal Inference: Using causal models to distinguish true mechanistic drivers of ageing from mere associations.
Automated Data Harmonization: Addressing data missingness, batch effects, and site heterogeneity through advanced imputation and harmonization pipelines.
Mechanistic Synthesis: Hybridizing data-driven approaches with mechanistic insights (e.g., biophysical aging theories, system-specific degradation laws) for further interpretability and extrapolation.

Overall, the data-driven ageing model represents an integrative, rigorously validated approach that leverages temporal and multidimensional biomarker dynamics for forecasting, intervention targeting, and fundamental ageing research (Dunbayeva et al., 13 Aug 2025, Pierson et al., 2018, Santos et al., 2021, Chen et al., 2024, Farrell et al., 2021).